Antitumor efficacy of edotecarin as a single agent and in combination with chemotherapy agents in a xenograft model.

Abstract

The novel indolocarbazole edotecarin (J-107088, formerly ED-749) differs from other topoisomerase I inhibitors both pharmacokinetically and pharmacodynamically. In vitro, it is more potent than camptothecins and has a variable cytotoxic activity in 31 different human cancer cell lines. Edotecarin also possesses greater than additive inhibitory effects on cell proliferation when used in combination with other agents tested in vitro against various cancer cell lines. The present in vivo studies were done to extend the in vitro findings to characterize the antitumor effects of edotecarin when used either alone or in combination with other agents (i.e., 5-fluorouracil, irinotecan, cisplatin, oxaliplatin, and SU11248) in the HCT-116 human colon cancer xenograft model. Treatment effects were based on the delay in onset of an exponential growth of tumors in drug-treated versus vehicle control-treated groups. In all studies, edotecarin was active both as a single agent and in combination with other agents. Combination therapy resulted in greater than additive effects, the extent of which depended on the specific dosage regimen. Toxicity in these experiments was minimal. Of all 359 treated mice, the six that died of toxicity were in the high-dose edotecarin/oxaliplatin group. The results suggest that edotecarin may serve as effective chemotherapy of colon cancer when used as a single agent, in combination with standard regimens and other topoisomerase inhibitors or with novel agents, such as the multitargeted tyrosine kinase inhibitor SU11248.

• Authors: Marina Ciomei, Valter Croci, Antonella Ciavolella, Dario Ballinari, Enrico Pesenti
• Journal: Clinical cancer research : an official journal of the American Association for Cancer Research (Clin Cancer Res) Vol. 12 Issue 9 Pg. 2856-61 (May 01 2006) ISSN: 1078-0432 [Print] United States
• PMID: 16675581 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Carbazoles
• Indoles
• Topoisomerase I Inhibitors
• edotecarin

Topics

• Animals
• Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
• Carbazoles (administration & dosage, therapeutic use)
• Cell Division (drug effects)
• Cell Line, Tumor
• Colonic Neoplasms (drug therapy, pathology)
• Female
• Humans
• Indoles (administration & dosage, therapeutic use)
• Mice
• Mice, Inbred BALB C
• Mice, Nude
• Topoisomerase I Inhibitors
• Transplantation, Heterologous